Verastem raises $32 million to develop targeted cancer stem cell therapies

[News]

Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.

More... (http://www.news-medical.net/news/20110714/Verastem-raises-2432-million-to-develop-targeted-cancer-stem-cell-therapies.aspx)